Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Rachel Jimenez, M.D.

Concepts (249)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms362023211782.010 Why?
Radiation Oncology1120235721.800 Why?
Radiotherapy, Intensity-Modulated320227981.440 Why?
Breast Implantation620222251.170 Why?
Mammaplasty5202212681.140 Why?
Radiotherapy Planning, Computer-Assisted12202216771.080 Why?
Breast Implants320224140.880 Why?
Radiotherapy, Conformal420225480.860 Why?
Radiotherapy Dosage11202229150.850 Why?
Mastectomy11202218610.780 Why?
Thoracic Wall320182030.650 Why?
Breast Neoplasms, Male120212130.640 Why?
Tattooing12019570.620 Why?
Radiation Injuries3202211960.600 Why?
Sarcopenia120233780.600 Why?
Mammary Neoplasms, Animal120181230.570 Why?
Curriculum9202237860.560 Why?
Medical Oncology4202223410.520 Why?
Mastectomy, Segmental320219740.520 Why?
Benchmarking1202210560.510 Why?
Organs at Risk420223670.500 Why?
Mediastinal Neoplasms120184030.500 Why?
Breast4202119720.460 Why?
Protons4202211010.410 Why?
Women's Health1202220820.410 Why?
Neuroectodermal Tumors, Primitive120131370.400 Why?
Pituitary Neoplasms1202113220.400 Why?
Neoplasms, Second Primary1202010610.400 Why?
Supratentorial Neoplasms120131560.390 Why?
Heart3202244290.390 Why?
Ventricular Dysfunction, Left1202221440.380 Why?
Radiobiology22020890.330 Why?
Lymphoma1201818960.310 Why?
Internship and Residency4202359470.300 Why?
Chemotherapy, Adjuvant4202335520.300 Why?
Cerebellar Neoplasms120135900.300 Why?
Medulloblastoma120136820.290 Why?
Lymph Nodes1201934680.290 Why?
Photons420195920.290 Why?
Female4420233966600.270 Why?
Humans6520237670400.260 Why?
Neoplasms62023223500.230 Why?
Clinical Clerkship320155690.230 Why?
Cultural Diversity220233730.220 Why?
Patient Participation1201314440.220 Why?
Neoplasm Recurrence, Local6202394100.210 Why?
Hypertension1202286150.200 Why?
Seroma12022750.200 Why?
Program Evaluation4202025050.200 Why?
Family Leave12021180.190 Why?
Supreme Court Decisions120221350.180 Why?
Education, Nursing12021830.180 Why?
Relative Biological Effectiveness220213130.170 Why?
Sick Leave120211050.170 Why?
Clinical Trials as Topic3202380480.170 Why?
Cranial Irradiation220133930.160 Why?
Accreditation120234770.160 Why?
Students, Medical4202119650.160 Why?
Thorax120225560.160 Why?
Physics12019920.160 Why?
Rib Fractures120201240.160 Why?
Troponin120225360.160 Why?
Retrospective Studies132023816590.150 Why?
Education, Medical, Graduate2202324200.150 Why?
Craniopharyngioma120212790.150 Why?
Canada2202221270.150 Why?
Necrosis1202216140.150 Why?
Nausea120216820.150 Why?
Lymphatic Metastasis2201829000.140 Why?
Safety1202211570.140 Why?
Vomiting120216550.140 Why?
Hematoma120227660.140 Why?
Moyamoya Disease120212740.140 Why?
Policy120215130.140 Why?
Radiation-Sensitizing Agents120193480.140 Why?
Radiation Tolerance120194760.130 Why?
Patient Care Planning120219030.130 Why?
Physician-Patient Relations3202132660.130 Why?
Congresses as Topic120208120.130 Why?
Treatment Outcome112023652950.120 Why?
Patient Positioning120183320.120 Why?
Aged1420231713190.120 Why?
Antineoplastic Agents, Hormonal1202315360.120 Why?
Tumor Burden1202119030.120 Why?
Asymptomatic Diseases120185880.120 Why?
Cisplatin1202116560.120 Why?
Postoperative Care2201814800.120 Why?
Postoperative Complications32022158240.110 Why?
Pulmonary Fibrosis120185050.110 Why?
Disease-Free Survival2202168440.110 Why?
Fatigue1202115560.110 Why?
Vision Disorders1202110900.110 Why?
Small Molecule Libraries120197420.110 Why?
Middle Aged1820232232330.100 Why?
Headache1202112610.100 Why?
Quality of Life52022134850.100 Why?
Health Services Needs and Demand1202014050.100 Why?
Propensity Score1202019710.100 Why?
Ventricular Function, Left2202239340.100 Why?
Needs Assessment1201811410.100 Why?
Acculturation120131790.090 Why?
Surgical Flaps1202016800.090 Why?
Terminal Care2201317700.090 Why?
Schizophrenia, Paranoid120111020.090 Why?
Endocrine System Diseases120132500.090 Why?
Adult1620232233170.090 Why?
Stroke Volume2202256180.090 Why?
Proto-Oncogene Proteins p21(ras)1201917610.090 Why?
Terminally Ill120132400.090 Why?
Sleep Initiation and Maintenance Disorders1202011070.090 Why?
Ambulatory Care1202127800.090 Why?
Attitude to Death120134000.090 Why?
Bone Density Conservation Agents120177970.090 Why?
Peptide Fragments1202251410.080 Why?
Massachusetts2202188900.080 Why?
Echocardiography1202250420.080 Why?
Pectoralis Muscles22020860.080 Why?
Feedback320217970.080 Why?
Prospective Studies62022548860.080 Why?
Radiotherapy, Adjuvant3202017880.080 Why?
Antineoplastic Combined Chemotherapy Protocols32020118720.080 Why?
United States72022729710.080 Why?
Interviews as Topic2201327410.080 Why?
Patient Preference220139470.080 Why?
Young Adult52023599800.070 Why?
Feasibility Studies1201953110.070 Why?
Receptor, erbB-21201825990.070 Why?
Career Choice120147690.070 Why?
Radiology1202121060.070 Why?
Kaplan-Meier Estimate1201865130.070 Why?
Hearing Loss, Sensorineural120137830.070 Why?
Follow-Up Studies42022393170.070 Why?
Body Height1201315650.070 Why?
Genomics1202359240.070 Why?
Hospice Care120136780.070 Why?
Cultural Competency120093030.070 Why?
Education, Medical, Undergraduate1201510870.070 Why?
Survival Rate22018128230.060 Why?
Infant22021364850.060 Why?
Bone Neoplasms1201725630.060 Why?
Cross-Sectional Studies22023263250.060 Why?
Radiosurgery1201413300.060 Why?
Child, Preschool22021426060.060 Why?
Neoplasm Staging42021112170.060 Why?
Mass Screening1202054560.060 Why?
Male1120233642030.060 Why?
Neoadjuvant Therapy3202029020.050 Why?
Coronavirus Infections1202031120.050 Why?
Cause of Death1201337170.050 Why?
Lung22018100760.050 Why?
Pneumonia, Viral1202032340.050 Why?
Brain Neoplasms2201491080.050 Why?
Aged, 80 and over42023595480.050 Why?
Consensus2202132070.040 Why?
Linear Energy Transfer120211540.040 Why?
Governing Board12019500.040 Why?
Maximum Tolerated Dose120218960.040 Why?
Program Development2201512980.040 Why?
Administrative Personnel120191850.040 Why?
Logistic Models12013132840.040 Why?
Pandemics3202287360.040 Why?
Surgical Mesh120203150.030 Why?
Costs and Cost Analysis1202216660.030 Why?
Radiology, Interventional120214830.030 Why?
Longitudinal Studies12013147660.030 Why?
Cost Allocation12016480.030 Why?
Drug Screening Assays, Antitumor120197190.030 Why?
Lung Neoplasms22019134910.030 Why?
Certification120194200.030 Why?
Single-Blind Method1202015870.030 Why?
Cost-Benefit Analysis2202155370.030 Why?
Educational Measurement2201512590.030 Why?
Phenylurea Compounds120195310.030 Why?
Models, Econometric120162150.030 Why?
Fluorouracil1202016520.030 Why?
Gene Expression Regulation, Leukemic120196580.030 Why?
Organ Specificity1202019660.030 Why?
Device Removal120206430.030 Why?
Monte Carlo Method1202012500.030 Why?
Prognosis32023299630.030 Why?
DNA Breaks, Double-Stranded120196050.030 Why?
Clinical Trials, Phase III as Topic120178780.030 Why?
Chicago120142550.030 Why?
Carcinoma, Intraductal, Noninfiltrating120209340.030 Why?
Pyrazines1201912040.030 Why?
Diphosphonates120176330.030 Why?
Child12021807710.030 Why?
Adolescent12021890460.030 Why?
Markov Chains120169760.020 Why?
Advance Directives120132490.020 Why?
Imidazoles1201711690.020 Why?
Randomized Controlled Trials as Topic22019103930.020 Why?
Fear1202014960.020 Why?
Catheterization1201614300.020 Why?
Social Support1202021920.020 Why?
Clinical Competence2201848590.020 Why?
Tomography, X-Ray Computed32018207410.020 Why?
Age Factors22017184010.020 Why?
Retreatment120115980.020 Why?
Reoperation1202043250.020 Why?
Disease Management1202025310.020 Why?
Quality-Adjusted Life Years1201617410.020 Why?
Delusions120113000.020 Why?
Life Expectancy1201612480.020 Why?
Hospitals, Teaching1201411560.020 Why?
Combined Modality Therapy1202185350.020 Why?
Cell Survival1201957500.020 Why?
Proportional Hazards Models12023125360.020 Why?
Patient Selection1202042560.020 Why?
Communication1202239040.020 Why?
Radiometry120138180.020 Why?
Societies, Medical1201939640.020 Why?
Biopsy1201967770.020 Why?
Multivariate Analysis12020120690.020 Why?
Hospitals, General120118040.020 Why?
Decision Support Systems, Clinical1201611780.020 Why?
Animals120181689650.020 Why?
Faculty120093830.020 Why?
Small Cell Lung Carcinoma120114540.020 Why?
Steroids120119370.020 Why?
Problem-Based Learning120093600.020 Why?
Internet1201831140.020 Why?
Health Care Surveys1201324280.020 Why?
Remission Induction1201124080.020 Why?
Risk Factors32020748860.020 Why?
Academic Medical Centers1201527830.010 Why?
Heart Ventricles1201738370.010 Why?
Recurrence1201785040.010 Why?
Survival Analysis12017100920.010 Why?
HIV Infections12011175420.010 Why?
Pilot Projects1201887320.010 Why?
Dexamethasone1201119630.010 Why?
Mutation22019302110.010 Why?
Time Factors22018401540.010 Why?
Cell Proliferation12019104550.010 Why?
Adaptation, Psychological1201326620.010 Why?
Cell Line, Tumor12019170970.010 Why?
Coronary Disease1201659140.010 Why?
Registries1201783510.010 Why?
Boston1201493600.010 Why?
Sensitivity and Specificity12016146720.010 Why?
Caregivers1201323020.010 Why?
Radiography1201169750.010 Why?
Palliative Care1201136410.010 Why?
Reproducibility of Results12013201690.010 Why?
Disease Progression12011136460.010 Why?
Carcinoma, Non-Small-Cell Lung1201153890.010 Why?
Colorectal Neoplasms1201169660.010 Why?
Magnetic Resonance Imaging12014365820.000 Why?
Jimenez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (249)
Explore
_
Co-Authors (97)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.